S.Biomedics Co., Ltd. (KOSDAQ:304360)

South Korea · Delayed Price · Currency is KRW

17,310

+360 (2.12%)

At close: Jul 27, 2026

S.Biomedics Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	16,483	16,548	13,734	13,108	12,113	8,868
Revenue Growth	5.73%	20.49%	4.77%	8.22%	36.59%	66.72%
Gross Profit	7,705	7,547	6,707	6,554	6,111	4,319
Operating Income	-9,644	-8,344	-5,442	-5,989	-3,752	-4,628
Net Income	-8,221	-8,122	-6,691	-10,321	-6,327	-5,667
Earnings Per Share	-683.46	-684.07	-581.66	-944.09	-619.09	-558.24
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	15,883	2,352	1,892	1,727	920.03
Overseas	664.7	11,382	11,216	10,386	7,948
Total	16,548	13,734	13,108	12,113	8,868

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	11,136	14,661	23,950	10,658	7,419	12,881
Total Debt	13,149	12,205	14,160	11,995	13,796	6,808
Net Cash (Debt)	-2,014	2,456	9,790	-1,337	-6,377	6,073
Net Cash Growth	-	-74.91%	-	-	-	-11.29%
Net Cash Per Share	-167.41	206.86	851.08	-122.35	-624.02	598.26

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-7,264	-3,981	-3,500	-6,149	-3,205	-3,287
Capital Expenditures	-4,672	-4,604	-1,390	-1,847	-9,295	-474.49
Free Cash Flow	-11,936	-8,584	-4,890	-7,996	-12,501	-3,762
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	46.75%	45.61%	48.84%	50.00%	50.45%	48.70%
Operating Margin	-58.51%	-50.42%	-39.62%	-45.69%	-30.98%	-52.19%
Pretax Margin	-41.09%	-41.15%	-41.92%	-69.68%	-43.01%	-59.19%
Profit Margin	-49.87%	-49.08%	-48.72%	-78.73%	-52.23%	-63.90%
FCF Margin	-72.42%	-51.88%	-35.61%	-61.00%	-103.20%	-42.42%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13.01	27.40	14.80	9.95	-	-